Company Filing History:
Years Active: 2016
Title: Innovations of Nicholas Juleff in Foot-and-Mouth Disease Research.
Introduction
Nicholas Juleff is a prominent inventor based in Guildford, GB. He has made significant contributions to the field of virology, particularly in the study of foot-and-mouth disease. His work focuses on developing innovative solutions to combat this viral infection that affects livestock.
Latest Patents
Nicholas Juleff holds a patent for a modified foot-and-mouth disease virus (FMDV) VP1 capsid protein. This invention provides a VP1 capsid protein that comprises an entity of interest (EOI). The EOI sequence may include an epitope tag, an immunomodulatory molecule, or a target molecule. Additionally, the invention encompasses an FMDV vaccine that utilizes this VP1 capsid protein to prevent foot-and-mouth disease.
Career Highlights
Juleff's career is marked by his dedication to research and innovation in the field of infectious diseases. His work at The Pirbright Institute has positioned him as a key figure in the development of vaccines and therapeutic strategies against viral infections.
Collaborations
Nicholas Juleff collaborates with various experts in his field, including his coworker Julian Seago. These collaborations enhance the research efforts at The Pirbright Institute and contribute to advancements in virology.
Conclusion
Nicholas Juleff's innovative work in developing a modified FMDV VP1 capsid protein and vaccine demonstrates his commitment to improving animal health and disease prevention. His contributions are vital in the ongoing fight against foot-and-mouth disease.